COVIVIO (COV.PA) Stock Fundamental Analysis
EPA:COV - Euronext Paris - Matif - FR0000064578 - REIT - Currency: EUR
COV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 43 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year COV was profitable.
COV had a positive operating cash flow in the past year.
COV had positive earnings in 4 of the past 5 years.
Each year in the past 5 years COV had a positive operating cash flow.
1.2 Ratios
The Return On Assets of COV (-2.90%) is worse than 72.50% of its industry peers.
COV has a Return On Equity of -9.06%. This is in the lower half of the industry: COV underperforms 75.00% of its industry peers.
COV has a worse Return On Invested Capital (3.07%) than 60.00% of its industry peers.
COV had an Average Return On Invested Capital over the past 3 years of 2.67%. This is in line with the industry average of 3.77%.
The last Return On Invested Capital (3.07%) for COV is above the 3 year average (2.67%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.9% | ||
| ROE | -9.06% | ||
| ROIC | 3.07% |
ROA(3y)-0.05%
ROA(5y)0.81%
ROE(3y)-0.4%
ROE(5y)2.4%
ROIC(3y)2.67%
ROIC(5y)2.67%
1.3 Margins
The Operating Margin of COV (74.52%) is comparable to the rest of the industry.
COV's Operating Margin has improved in the last couple of years.
COV has a Gross Margin of 79.59%. This is in the better half of the industry: COV outperforms 62.50% of its industry peers.
COV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 74.52% | ||
| PM (TTM) | N/A | ||
| GM | 79.59% |
OM growth 3Y13.27%
OM growth 5Y12.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y1.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COV is destroying value.
The number of shares outstanding for COV has been increased compared to 1 year ago.
COV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for COV is higher compared to a year ago.
2.2 Solvency
COV has an Altman-Z score of 0.56. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.56, COV is doing worse than 90.00% of the companies in the same industry.
The Debt to FCF ratio of COV is 20.01, which is on the high side as it means it would take COV, 20.01 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 20.01, COV is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.24 is on the high side and indicates that COV has dependencies on debt financing.
The Debt to Equity ratio of COV (1.24) is worse than 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 20.01 | ||
| Altman-Z | 0.56 |
ROIC/WACC0.55
WACC5.55%
2.3 Liquidity
COV has a Current Ratio of 1.32. This is a normal value and indicates that COV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, COV belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
A Quick Ratio of 1.19 indicates that COV should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.19, COV belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
COV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.81%.
COV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.53% yearly.
COV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.96%.
Measured over the past years, COV shows a decrease in Revenue. The Revenue has been decreasing by -6.88% on average per year.
EPS 1Y (TTM)-4.81%
EPS 3Y2.02%
EPS 5Y-2.53%
EPS Q2Q%-5.08%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y-4.28%
Revenue growth 5Y-6.88%
Sales Q2Q%1.2%
3.2 Future
COV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.13% yearly.
Based on estimates for the next years, COV will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y-1.54%
EPS Next 2Y-0.32%
EPS Next 3Y0.64%
EPS Next 5Y0.13%
Revenue Next Year6.14%
Revenue Next 2Y5.02%
Revenue Next 3Y4.46%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.83, the valuation of COV can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of COV indicates a somewhat cheap valuation: COV is cheaper than 67.50% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. COV is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.58, which indicates a very decent valuation of COV.
COV's Price/Forward Earnings ratio is in line with the industry average.
COV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.83 | ||
| Fwd PE | 11.58 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COV is on the same level as its industry peers.
COV's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.15 | ||
| EV/EBITDA | 17.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.32%
EPS Next 3Y0.64%
5. Dividend
5.1 Amount
COV has a Yearly Dividend Yield of 6.38%, which is a nice return.
COV's Dividend Yield is a higher than the industry average which is at 8.20.
Compared to an average S&P500 Dividend Yield of 2.29, COV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.38% |
5.2 History
The dividend of COV decreases each year by -29.38%.
Dividend Growth(5Y)-29.38%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
The earnings of COV are negative and hence is the payout ratio. COV will probably not be able to sustain this dividend level.
DP-10.27%
EPS Next 2Y-0.32%
EPS Next 3Y0.64%
EPA:COV (2/21/2025, 7:00:00 PM)
51.45
+0.05 (+0.1%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners39.84%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap5.73B
Analysts81.11
Price Target62.59 (21.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.38% |
Yearly Dividend0.75
Dividend Growth(5Y)-29.38%
DP-10.27%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.5%
PT rev (3m)4.14%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.51%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.83 | ||
| Fwd PE | 11.58 | ||
| P/S | 5.35 | ||
| P/FCF | 10.15 | ||
| P/OCF | 5.3 | ||
| P/B | 0.7 | ||
| P/tB | 0.72 | ||
| EV/EBITDA | 17.97 |
EPS(TTM)4.35
EY8.45%
EPS(NY)4.44
Fwd EY8.63%
FCF(TTM)5.07
FCFY9.86%
OCF(TTM)9.71
OCFY18.87%
SpS9.62
BVpS73.06
TBVpS71.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.9% | ||
| ROE | -9.06% | ||
| ROCE | 3.44% | ||
| ROIC | 3.07% | ||
| ROICexc | 3.26% | ||
| ROICexgc | 3.28% | ||
| OM | 74.52% | ||
| PM (TTM) | N/A | ||
| GM | 79.59% | ||
| FCFM | 52.73% |
ROA(3y)-0.05%
ROA(5y)0.81%
ROE(3y)-0.4%
ROE(5y)2.4%
ROIC(3y)2.67%
ROIC(5y)2.67%
ROICexc(3y)2.76%
ROICexc(5y)2.78%
ROICexgc(3y)2.78%
ROICexgc(5y)2.8%
ROCE(3y)2.99%
ROCE(5y)2.99%
ROICexcg growth 3Y11.05%
ROICexcg growth 5Y3.16%
ROICexc growth 3Y11.07%
ROICexc growth 5Y3.21%
OM growth 3Y13.27%
OM growth 5Y12.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y1.65%
F-Score6
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 20.01 | ||
| Debt/EBITDA | 11.56 | ||
| Cap/Depr | 691.5% | ||
| Cap/Sales | 48.22% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.88% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 0.56 |
F-Score6
WACC5.55%
ROIC/WACC0.55
Cap/Depr(3y)788.26%
Cap/Depr(5y)788.9%
Cap/Sales(3y)57.96%
Cap/Sales(5y)58.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.81%
EPS 3Y2.02%
EPS 5Y-2.53%
EPS Q2Q%-5.08%
EPS Next Y-1.54%
EPS Next 2Y-0.32%
EPS Next 3Y0.64%
EPS Next 5Y0.13%
Revenue 1Y (TTM)-13.96%
Revenue growth 3Y-4.28%
Revenue growth 5Y-6.88%
Sales Q2Q%1.2%
Revenue Next Year6.14%
Revenue Next 2Y5.02%
Revenue Next 3Y4.46%
Revenue Next 5YN/A
EBIT growth 1Y1.61%
EBIT growth 3Y8.42%
EBIT growth 5Y4.47%
EBIT Next Year49.88%
EBIT Next 3Y18.18%
EBIT Next 5Y14.85%
FCF growth 1Y1118.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.12%
OCF growth 3Y26.98%
OCF growth 5Y3%